Eligibility Criteria

Checkout our iOS App for a better way to browser and research.

In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person:

  1. Has a terminal illness;
  2. Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration;
  3. Has been given a recommendation by the physician for an investigational drug, biological product, or device; and
  4. Has given written informed consent for the use of the investigational drug, biological product, or device.

(Code 1981, §31-52-4, enacted by Ga. L. 2016, p. 345, § 1/HB 34.)


Download our app to see the most-to-date content.